NCT05623228CompletedPhase 2
The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training.
The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training in Schizophrenia and Treatment Resistant Schizophrenia. This is a Non-randomized Trial. The Therapy Lasts 60 Sessions.
Source: ClinicalTrials.gov · Last updated 5 Mar 2025
Brief summary (registry, in English)
The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals with schizophrenia and treatment resistant schizophrenia. Is it effective and efficacious?
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 4 Nov 2022
- Start date
- Nov 2022
- Primary completion date
- Mar 2024
- Lead sponsor
- Rakitzi, Stavroula
- Diseases
- Schizophrenia
- NCT number
- NCT05623228
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 35
- From Nov 2022 to the primary completion date, Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other psychotic disorders
Other
- Relapse and hospitalization
- Substance abuse
Who the study is looking for
- Diagnosis of schizophrenia
- No relapse and hospitalization
- Ambulant psychiatric treatment
Age in the registry: 19 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stavroula Rakitzi Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.